Company performance
Current Price
as of Jan 20, 2025$191.88
P/E Ratio
56.74
Market Cap
$12.6B
Description
Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Cochlear Implants, Services, and Acoustics. The Cochlear Implants segment deals with the treatment pathway for acquired or progressive hearing loss. The Services segment offers sound processor upgrades, accessories, and others. The Acoustic segment is for the bone conduction systems. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.
Metrics
Overview
- HQSydney, NS
- SectorHealth Technology
- IndustryMedical Specialties
- TickerCOH
- Price$191.876386+1.85%
Trading Information
- Market cap$12.60B
- Float94.58%
- Average Daily Volume (1m)83,640
- Average Daily Volume (3m)130,786
- EPS$5.44
Company
- Revenue$2.26B
- Rev growth (1yr)15.47%
- Net income$356.80M
- Gross margin75.11%
- EBITDA margin26.85%
- EBITDA$606.40M
- EV$21.56B
- EV/Revenue9.55
- P/E56.74
- P/S8.99
- P/B10.97
Documents
Factset